Description
INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS
Modification chain · 4 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2019-03-13+$0= $0
- Mod P000012019-03-14+$0= $0
- Mod P000022019-03-14+$0= $0
- Mod P000032019-07-17+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2019-03-13 | +$0 | $0 | INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-03-14 | +$0 | $0 | TEMPORARY PRICE REDUCTION |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-03-14 | +$0 | $0 | TEMPORARY PRICE REDUCTION |
| Mod P00003· OTHER ADMINISTRATIVE ACTION | 2019-07-17 | +$0 | $0 | INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI UMD1NK9KU143)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C77026N0048 | NATIONAL CMOP OFFICE (36C770) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $236,612 | FY2026 |
| 36C77026N0018 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $709,836 | FY2026 |
| 36C77025N0077 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $143,561 | FY2025 |
| 36E79725A0009 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2025 |
| 36C77024N0090 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $653,990 | FY2024 |
| 36F79719D0246 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2019 |
Other recipients under 6505 from NAC FEDERAL SUPPLY SCHEDULE (36F797) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36F79726D058E | REVOLUTION MEDICINES, INC. | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2026 |
| 36F79726D0172 | LUNDBECK LLC | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2026 |
| 36F79726D0195 | MILESTONE PHARMACEUTICALS USA, INC. | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2026 |
| 36F79726D0165 | RECKITT BENCKISER LLC | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2026 |
| 36F79726D0118 | OMEROS CORPORATION | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36F79719D038E_3600 · retrieved 2026-09-26.